Remedy Meds Tirzepatide Review: Cost & Honest Verdict (2026)

Remedy Meds is a telehealth provider offering compounded semaglutide and tirzepatide programs, but the ranking's own research found very limited public information on program details beyond pricing and molecule availability. Every fact here comes from the company's own published program.

What Remedy Meds is

Remedy Meds is a telehealth provider, offering both compounded semaglutide and tirzepatide, with an online intake reviewed by a licensed clinician before treatment begins.

What Remedy Meds costs

Tirzepatide starts at $399/month for the starting dose — above the market median for comparable compounded programs, with pricing not published until after the intake.

The brand-vs-compounded question

Remedy Meds dispenses compounded semaglutide and tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Remedy Meds's real strengths: both semaglutide and tirzepatide available, and compounded GLP-1 access. The trade-off is significant, and this review flags it directly: very limited public information on program specifics beyond pricing and molecule availability — no named compounding pharmacy, no accreditation badge, and no named clinical leadership were found. As with any GLP-1 program, and especially one this thin on public disclosure at an above-median price, ask directly about pharmacy sourcing before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Remedy Meds's dual-molecule availability is a modest positive, but this review found very little else to verify, and its starting price runs above the market median. Ask directly before committing. For a provider with fuller public disclosure at a lower price, compare it against Ondra Health or NewSelf. See our best tirzepatide providers ranking for the full field.